key: cord-0942661-8eoe21bu authors: Halabi, Katia C.; Saiman, Lisa; Zachariah, Philip title: The Epidemiology of Respiratory Syncytial Virus in New York City during the COVID-19 Pandemic Compared with Previous Years date: 2021-10-30 journal: J Pediatr DOI: 10.1016/j.jpeds.2021.10.057 sha: 209b085bea734cc410d411e9892d7dd6fb19b261 doc_id: 942661 cord_uid: 8eoe21bu nan with inter-seasonal resurgence. Children were more likely to have severe disease with less known risk factors in comparison to controls from 2018-2019. Overall co-detection rates were similar but with higher parainfluenza, rhinovirus/enterovirus, and lower influenza proportions compared with previous seasons. Coronavirus disease 2019 (COVID-19) had an impact on the epidemiology of respiratory syncytial virus (RSV) during the 2020-2021 winter season in the US. 1 These epidemiologic changes could be related to interactions between respiratory viruses and/or ongoing COVID-19 mitigation efforts. We describe RSV infections at a children's hospital during the first winter RSV season (2020-2021) since the advent of COVID-19 and compare the epidemiology of these infections to RSV infections in previous seasons. We hypothesized that the public health mitigation measures implemented in response to the pandemic would reduce overall rates of medically-attended RSV, similar to observations made for influenza and RSV in early 2020, 2 but that the characteristics of these patients would be similar to the characteristics of patients with RSV in previous seasons. We conducted a retrospective review of children and adolescents with RSV who presented to the New York-Presbyterian Morgan Stanley Children's Hospital Emergency Department and had a positive test for RSV on nasal swab samples tested by a multiplex RTpolymerase chain reaction (PCR) assay (FilmArray Panel, BioFire Diagnostics, Inc). Children attended only in the Emergency Department were offered testing with multiplex RT-PCR at the discretion of the treating physician. Testing availability for this assay did not change during the study period. To assess changes in the epidemiology of medically-attended RSV, we identified cases age 21 years from November 1 st to April 30 th during three respiratory viral seasons (2018-2019, 2019-2020, and 2020-2021). A broader age group was selected to fully ascertain potential epidemiological changes. New York City (NYC) likely occurred prior to March 2020. 3 We excluded patients with codetections of other respiratory pathogens from this analysis. For each patient, we collected presenting symptoms, clinical syndromes (bronchiolitis, croup, asthma/reactive airway disease (RAD) exacerbation) noted in the electronic medical record by attending physicians, comorbidities (prematurity, cardiac disease, asthma/RAD), sick contacts if noted, and severity of disease (defined as inpatient hospitalization, oxygen saturation ≤94% at presentation, and/or the need for respiratory support). Second, we graphically compared the number and temporal distribution of cases between years. Lastly, we compared the overall proportion and distribution of other respiratory virus co-detections among all three seasons. Categorical and continuous variables were compared using the Fisher exact, Chi-squared, and Wilcoxon rank-sum test, as appropriate. The Columbia University Irving Medical Center IRB approved the study. (Table I) . Significantly more cases in 2020-2021 were hospitalized and required oxygen supplementation. The overall proportion of viral co-detections was similar across the three seasons, but the distribution of some pathogens differed (Table II ; available at www.jpeds.com). Rhinovirus/enterovirus was most commonly co-detected in all three seasons with the highest proportion of rhinovirus/enterovirus noted in 2020-2021. Parainfluenza viruses were detected at a significantly higher rate in 2020-2021 than previous seasons. Lower numbers of medically-attended RSV were observed in the first winter since the onset of the COVID-19 pandemic in NYC, as described in the southern hemisphere. 4 Possibly consistent with our hypothesis, that anti-SARS-CoV-2 mitigation measures were instrumental in this decrease, current and comparator season were similar in multiple aspects (median age, bronchiolitis as the predominant syndrome, and proportion of viral codetections). However, there were some epidemiologic differences. Despite lack of known risk factors, a higher proportion of children had severe disease in 2020-2021. This could potentially reflect families avoiding emergency room care for milder illness during the pandemic. Lower rates of asthma exacerbations have been noted during COVID-19 5 , so it is intriguing that in the 2020-2021 RSV cohort, asthma was a less common presentation. Differences in the distribution of some co-detected viruses were observed. with these viruses in the larger population. The increase in RSV cases at the end of winter into early Spring has been observed throughout NY state 1 and suggests inter-seasonal RSV resurgence associated with the relaxation of COVID-19 preventive efforts similar to observations in Australia. 6 This has implications for the duration of palivizumab prophylaxis that may need to be tailored more specifically to local epidemiology of RSV. In our institution, palivizumab prophylaxis was extended as per the recommendation of the Department of Health. Limitations of this study include possible differences in health seeking behavior or testing biases between seasons. Ongoing RSV surveillance is essential to fully explore the continuing impact of the COVID-19 pandemic. J o u r n a l P r e -p r o o f 148 (12.7%)* 41 (3.5%) 108 (9.3%) 13 (1.1%)* 6 (0.5%) 87 (7.5%) 0 (0%) 29 (20.3%) 0 (0%) 11 (7.7%) 8 (5.6%) 0 (0%) 13 (9.1%) 1 (1.6%) The National Respiratory and Enteric Virus Surveillance System (NREVSS)-Respiratory Syncytial Virus Surveillance RSV State Trends Web site The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures